Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1

Cancer Gene Ther. 2022 Nov;29(11):1801-1802. doi: 10.1038/s41417-022-00479-w.

Yunfu Deng^{1

2}, Guangzhi Ma^{2

3}, Karin A Vallega², Dongsheng Wang², Mingliang Wang⁴, Changwei Wang⁴, Shaomeng Wang⁴, Suresh S Ramalingam², Shi-Yong Sun⁵

¹ Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
² Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA.
³ Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.
⁴ Departments of Medicinal Chemistry, Pharmacology and Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
⁵ Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA. ssun@emory.edu.

No abstract available

Publication types